KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alpha Metallurgical Resources (AMR) Cash & Equivalents (2017 - 2025)

Alpha Metallurgical Resources (AMR) has disclosed Cash & Equivalents for 9 consecutive years, with $366.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 24.01% to $366.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $366.0 million through Dec 2025, down 24.01% year-over-year, with the annual reading at $366.0 million for FY2025, 24.01% down from the prior year.
  • Cash & Equivalents hit $366.0 million in Q4 2025 for Alpha Metallurgical Resources, down from $408.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $484.6 million in Q3 2024 to a low of $72.3 million in Q2 2021.
  • Historically, Cash & Equivalents has averaged $284.7 million across 5 years, with a median of $299.0 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: plummeted 69.66% in 2021 and later surged 416.63% in 2022.
  • Year by year, Cash & Equivalents stood at $81.2 million in 2021, then skyrocketed by 271.76% to $301.9 million in 2022, then fell by 11.16% to $268.2 million in 2023, then skyrocketed by 79.55% to $481.6 million in 2024, then decreased by 24.01% to $366.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for AMR at $366.0 million in Q4 2025, $408.5 million in Q3 2025, and $449.0 million in Q2 2025.